Skip to main content
Erschienen in: Techniques in Coloproctology 5/2013

01.10.2013 | Original Article

Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival

verfasst von: R. Ghinea, R. Greenberg, I. White, E. Sacham-Shmueli, H. Mahagna, S. Avital

Erschienen in: Techniques in Coloproctology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Perioperative blood transfusion has been associated with a poor prognosis in patients undergoing surgery for colorectal cancer. The aim of this study was to evaluate risk factors for blood transfusion and its impact on long-term outcome exclusively in patients undergoing laparoscopic surgery for curable colorectal cancer.

Methods

Data were retrieved from a prospectively collected database of patients who underwent laparoscopic surgery for curable colorectal cancer over a 6-year period. Long-term data were collected from our outpatient clinic and personal contact when necessary.

Results

Two hundred and one patients underwent laparoscopic surgery for curable colorectal cancer (stage I–III). Sixty-eight (33.8 %) received blood transfusions during or after surgery. These patients were typically older, had lower preoperative hemoglobin levels, had a more advanced cancer, had a higher Charlson score, had a higher rate of complications and had a higher conversion rate. Kaplan–Meier overall survival analysis was significantly worse in patients who received blood transfusions (P = 0.004). Decreased disease-free survival was also observed in transfused patients; however, this did not reach statistical significance (P = 0.21). A multivariate analysis revealed that transfusion was not an independent risk factor for decreased overall and disease-free survival. The Charlson score was the only independent risk factor for overall survival (OR = 2.1, P = 0.002). Independent factors affecting disease-free survival were stage of disease, Charlson score and, to a lesser degree, age and body mass index.

Conclusions

Perioperative blood transfusion is associated with decreased long-term survival in patients undergoing laparoscopic resection for colorectal cancer. However, this association apparently reflects the poorer medical condition of patients requiring surgery and not a causative relationship.
Literatur
1.
Zurück zum Zitat Burrows L, Tartter P (1982) Effects of blood transfusions on colonic malignancy recurrence rate. Lancet 2:662PubMedCrossRef Burrows L, Tartter P (1982) Effects of blood transfusions on colonic malignancy recurrence rate. Lancet 2:662PubMedCrossRef
2.
Zurück zum Zitat Blumberg N, Agarwal MM, Chuang C (1985) Relation between recurrence of cancer of the colon and blood transfusion. BMJ 290:1037–1039PubMedCrossRef Blumberg N, Agarwal MM, Chuang C (1985) Relation between recurrence of cancer of the colon and blood transfusion. BMJ 290:1037–1039PubMedCrossRef
3.
Zurück zum Zitat Edna TH, Bjerkeset T (1998) Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 41:451–459PubMedCrossRef Edna TH, Bjerkeset T (1998) Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 41:451–459PubMedCrossRef
4.
Zurück zum Zitat Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M (2006) Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol) 18:60–66CrossRef Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M (2006) Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol) 18:60–66CrossRef
5.
Zurück zum Zitat Sabalić S, Kovacević D, Glavić Z et al (2006) The immunomodulation effect of allogenic blood transfusion in colorectal cancer—a new approach. Coll Antropol 30:885–893PubMed Sabalić S, Kovacević D, Glavić Z et al (2006) The immunomodulation effect of allogenic blood transfusion in colorectal cancer—a new approach. Coll Antropol 30:885–893PubMed
6.
Zurück zum Zitat Baumgartner JM, Nydam TL, Clarke JH, Banerjee A, Silliman CC, McCarter MD (2009) Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells. J Interferon Cytokine Res 29:333–338PubMedCrossRef Baumgartner JM, Nydam TL, Clarke JH, Banerjee A, Silliman CC, McCarter MD (2009) Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells. J Interferon Cytokine Res 29:333–338PubMedCrossRef
7.
Zurück zum Zitat Braga M, Pecorelli N, Frasson M, Vignali A, Zuliani W, Carlo VD (2011) Long-term outcomes after laparoscopic colectomy. World J Gastrointest Oncol 3:43–48PubMedCrossRef Braga M, Pecorelli N, Frasson M, Vignali A, Zuliani W, Carlo VD (2011) Long-term outcomes after laparoscopic colectomy. World J Gastrointest Oncol 3:43–48PubMedCrossRef
8.
Zurück zum Zitat Braga M, Vignali A, Zuliani W et al (2002) Metabolic and functional results after laparoscopic colorectal surgery: a randomized, controlled trial. Dis Colon Rectum 45:1070–1077PubMedCrossRef Braga M, Vignali A, Zuliani W et al (2002) Metabolic and functional results after laparoscopic colorectal surgery: a randomized, controlled trial. Dis Colon Rectum 45:1070–1077PubMedCrossRef
9.
Zurück zum Zitat Braga M, Vignali A, Gianotti L et al (2002) Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcome. Ann Surg 236:759–766PubMedCrossRef Braga M, Vignali A, Gianotti L et al (2002) Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcome. Ann Surg 236:759–766PubMedCrossRef
10.
Zurück zum Zitat Leung KL, Tsang KS, Ng MH et al (2003) Lymphocyte subsets and natural killer cell cytotoxicity after laparoscopically assisted resection of rectosigmoid carcinoma. Surg Endosc 17:1305–1310PubMedCrossRef Leung KL, Tsang KS, Ng MH et al (2003) Lymphocyte subsets and natural killer cell cytotoxicity after laparoscopically assisted resection of rectosigmoid carcinoma. Surg Endosc 17:1305–1310PubMedCrossRef
11.
Zurück zum Zitat Amato AC, Pescatori M (1998) Effect of perioperative blood transfusions on recurrence of colorectal cancer: metaanalysis stratified on risk factors. Dis Colon Rectum 41:570–585PubMedCrossRef Amato AC, Pescatori M (1998) Effect of perioperative blood transfusions on recurrence of colorectal cancer: metaanalysis stratified on risk factors. Dis Colon Rectum 41:570–585PubMedCrossRef
12.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
13.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef
14.
Zurück zum Zitat Frank SM, Savage WJ, Rothschild JA et al (2012) Variability in blood and blood component utilization as assessed by anaesthesia information management system. Anesthesiology 117:99–106PubMedCrossRef Frank SM, Savage WJ, Rothschild JA et al (2012) Variability in blood and blood component utilization as assessed by anaesthesia information management system. Anesthesiology 117:99–106PubMedCrossRef
15.
Zurück zum Zitat Amato A, Pescatori M (2006) Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 25:CD005033 Amato A, Pescatori M (2006) Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 25:CD005033
16.
Zurück zum Zitat Vignali A, Braga M, Zuliani W et al (2004) Laparoscopic colorectal surgery modifies risk factors for postoperative morbidity. Dis Colon Rectum 47:1686–1693PubMedCrossRef Vignali A, Braga M, Zuliani W et al (2004) Laparoscopic colorectal surgery modifies risk factors for postoperative morbidity. Dis Colon Rectum 47:1686–1693PubMedCrossRef
17.
Zurück zum Zitat Kiran RP, Delaney CP, Senagore AJ, Millward BL, Fazio VW (2004) Operative blood loss and use of blood products after laparoscopic and conventional open colorectal operations. Arch Surg 139:39–42PubMedCrossRef Kiran RP, Delaney CP, Senagore AJ, Millward BL, Fazio VW (2004) Operative blood loss and use of blood products after laparoscopic and conventional open colorectal operations. Arch Surg 139:39–42PubMedCrossRef
18.
Zurück zum Zitat Ohtani H, Tamamori Y, Arimoto Y, Nishiguchi Y, Maeda K, Hirakawa K (2012) A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and open colectomy for colon cancer. J Cancer 3:49–57PubMedCrossRef Ohtani H, Tamamori Y, Arimoto Y, Nishiguchi Y, Maeda K, Hirakawa K (2012) A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and open colectomy for colon cancer. J Cancer 3:49–57PubMedCrossRef
19.
Zurück zum Zitat Law WL, Poon JT, Fan JK, Lo OS (2012) Survival following laparoscopic versus open resection for colorectal cancer. Int J Colorectal Dis 27:1077–1085PubMedCrossRef Law WL, Poon JT, Fan JK, Lo OS (2012) Survival following laparoscopic versus open resection for colorectal cancer. Int J Colorectal Dis 27:1077–1085PubMedCrossRef
20.
Zurück zum Zitat Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J (1993) Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328:1372–1376PubMedCrossRef Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J (1993) Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328:1372–1376PubMedCrossRef
21.
Zurück zum Zitat Busch OR, Hop WC, Marquet RL, Jeekel J (1994) Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg 220:791–797PubMedCrossRef Busch OR, Hop WC, Marquet RL, Jeekel J (1994) Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg 220:791–797PubMedCrossRef
22.
Zurück zum Zitat Fleshman J, Sargent DJ, Green E et al (2007) Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 246:655–662PubMedCrossRef Fleshman J, Sargent DJ, Green E et al (2007) Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 246:655–662PubMedCrossRef
23.
Zurück zum Zitat Jayne DG, Guillou PJ, Thorpe H et al (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol 25:3061–3068PubMedCrossRef Jayne DG, Guillou PJ, Thorpe H et al (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol 25:3061–3068PubMedCrossRef
24.
Zurück zum Zitat Lacy AM, Delgado S, Castells A et al (2008) The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 248:1–7PubMedCrossRef Lacy AM, Delgado S, Castells A et al (2008) The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 248:1–7PubMedCrossRef
25.
Zurück zum Zitat Chan AC, Poon JT, Fan JK, Lo SH, Law WL (2008) Impact of conversion on the long-term outcome in laparoscopic resection of colorectal cancer. Surg Endosc 22:2625–2630PubMedCrossRef Chan AC, Poon JT, Fan JK, Lo SH, Law WL (2008) Impact of conversion on the long-term outcome in laparoscopic resection of colorectal cancer. Surg Endosc 22:2625–2630PubMedCrossRef
26.
Zurück zum Zitat White I, Greenberg R, Itah R, Inbar R, Schneebaum S, Avital S (2011) Impact of conversion on short and long-term outcome in laparoscopic resection of curable colorectal cancer. JSLS 15:182–187PubMedCrossRef White I, Greenberg R, Itah R, Inbar R, Schneebaum S, Avital S (2011) Impact of conversion on short and long-term outcome in laparoscopic resection of curable colorectal cancer. JSLS 15:182–187PubMedCrossRef
27.
Zurück zum Zitat Donohue JH, Williams S, Cha S et al (1995) Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study. J Clin Oncol 13:1671–1678PubMed Donohue JH, Williams S, Cha S et al (1995) Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study. J Clin Oncol 13:1671–1678PubMed
28.
Zurück zum Zitat Jagoditsch M, Pozgainer P, Klingler A, Tschmelitsch J (2006) Impact of blood transfusions on recurrence and survival after rectal cancer surgery. Dis Colon Rectum 49:1116–1130PubMedCrossRef Jagoditsch M, Pozgainer P, Klingler A, Tschmelitsch J (2006) Impact of blood transfusions on recurrence and survival after rectal cancer surgery. Dis Colon Rectum 49:1116–1130PubMedCrossRef
Metadaten
Titel
Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival
verfasst von
R. Ghinea
R. Greenberg
I. White
E. Sacham-Shmueli
H. Mahagna
S. Avital
Publikationsdatum
01.10.2013
Verlag
Springer Milan
Erschienen in
Techniques in Coloproctology / Ausgabe 5/2013
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-013-1014-y

Weitere Artikel der Ausgabe 5/2013

Techniques in Coloproctology 5/2013 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.